Eli Lilly introduces Ramiven (abemaciclib) in India
Abemaciclib is a CDK4/6 inhibitor which has now been approved for HR+ HER2 - node positive high-risk Early Breast Cancer (EBC)
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.